Sort   by:  
 Page size 
A detailed quantitative proteomic study upon neuronal differentiation of SHSY5Y by sequential exposure of RA+BDNF
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-10-22 | MSV000088256 | MassIVE
NRAS activating mutations occur in 15-25% of melanoma patients. However, this subtype is more aggressive and refractory to current treatment modalities, including targeted MEK inhibitors, immunotherapies, and the recently emerging RAS inhibitors. Accordingly, identifying novel therapeutic targets an...
ORGANISM(S): Homo sapiens (Human) 
2025-05-02 | PXD050244 | Pride
Sort   by:  
 Page size